MarketResearchReports.Biz announces addition of new report “Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” to its database
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
The Co-promotion and Co-marketing
Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report
provides comprehensive understanding and unprecedented access to the
co-promotion and co-marketing partnering agreements entered into by the worlds
leading healthcare companies.
Revised and updated 8th edition,
includes:
- Trends in co-promotion and co-marketing deals
- Co-promotion and co-marketing agreement structure
- Co-promotion and co-marketing contract documents
- Top co-promotion deals by value
- Top co-marketing deals by value
- Most active co-promotion dealmakers
- Most active co-marketing dealmakers
This report provides details of the
latest co-promotion and co-marketing agreements announced in the
pharmaceutical, biotechnology and diagnostic sectors.
Fully revised and updated, the
report provides details of co-promotion and co-marketing agreements from 2007
to mid 2013.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/co-promotion-and-co-marketing-partnering-terms-and-agreements-in-pharma-biotech-and-diagnostics
The report provides a detailed
understanding and analysis of how and why companies enter co-promotion and
co-marketing deals. The majority of deals are multicomponent whereby the
licensor retains either a right or option to co-promote/market the resultant
product of the research collaboration. There are also numerous pure
co-promotion/marketing deals whereby the products originator takes on a
co-promotion/marketing partner in order to maximize a products presence in the
marketplace.
Understanding the flexibility of a
prospective partner’s negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve during the
negotiation of terms. Whilst many smaller companies will be seeking details of the
payments clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases and
databases do not.
This report contains over 750 links
to online copies of actual co-promotion and co-marketing contract documents as
submitted to the Securities Exchange Commission by biopharma companies and
their partners.
Contract documents provide the
answers to numerous questions about a prospective partner’s flexibility on a
wide range of important issues, many of which will have a significant impact on
each party’s ability to derive value from the deal.
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/93025
The initial chapters of this report
provide an orientation of co-promotion and co-marketing dealmaking and business
activities.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an analysis of the trends in co-promotion and
co-marketing as well as a discussion on the merits of each type of deal.
Chapters 3 and 4 provide an overview of the structure of co-promotion and
co-marketing deals, respectively. Each chapter includes numerous case studies
to enable understanding of both pure co-promotion/marketing deals and
multicomponent deals where co-promotion/marketing forms a part.
Chapters 5 and 6 provide a review of the leading co-promotion and
co-marketing deals since 2007, respectively. Deals are listed by headline
value, signed by bigpharma, most active bigpharma, and most active of all
biopharma companies. Where the deal has an agreement contract published at the
SEC a link provides online access to the contract via the Current Agreements
deals and alliances database.
Chapter 7 provides a comprehensive listing of the top 50
bigpharma companies with a brief summary followed by a comprehensive listing of
co-promotion and co-marketing contract deals available in the public domain.
Where available, each deal title links via Current Agreements deals and
alliances database to an online version of the actual contract document,
providing easy access to each contract document on demand.
Chapters 8 and 9 provide a comprehensive and detailed review of co-promotion
and co-marketing deals signed and announced since 2007. Each chapter is
organized by A-Z, stage of development at signing, and therapeutic area. Each
deal title links via Weblink to an online version of the actual contract
document, providing easy access to each contract document on demand.
The report also includes numerous
table and figures that illustrate the trends and activities in co-promotion and
co-marketing dealmaking since 2007.
Browse All The Report Of This Publisher Visit: http://www.marketresearchreports.biz/publisher/20
In conclusion, this report provides
everything a prospective dealmaker needs to know about co-promotion and
co-marketing as an opportunity to participate in the commercialization of
either candidate compounds in development or products already on the market.
In addition, a comprehensive
appendix is provided organized by co promotion and co marketing partnering
company A-Z , stage of development, therapeutic target, technology type and
deal type definitions. Each deal title links via Weblink to an online version
of the deal record and where available, the contract document, providing easy
access to each contract document on demand.
In conclusion, this report provides
everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of antibody technologies and
products.
Key benefits
Co-promotion and Co-marketing Partnering
Terms and Agreements in Pharma, Biotech and Diagnostics provides the reader
with the following key benefits:
- In-depth understanding of co-promotion and co-marketing deal trends since 2007
- Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies
- Comprehensive access to over 750 actual co-promotion and co-marketing deals entered into by the world’s biopharma companies
- Detailed access to actual co-promotion and co-marketing contracts entered into by the leading fifty bigpharma companies
- Insight into the terms included in a co-promotion and co-marketing agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
No comments:
Post a Comment